CORPORATE INFORMATION
PRODUCT INFORMATION
Biosensors International Announces Japanese PMDA Approval for BioFreedom™ Ultra and US FDA Approval for BioFreedom™ Biolimus A9™ Coated Polymer Free Coronary Stent Systems
Morges 21 April 2022
Biosensors International Announces Enrollment of First Patient in the RISE™ SC study
Morges 4th February 2022
Biosensors International Group Ltd, announces CE Mark Approval for Biolimus A9™ Coated Cobalt Chromium Coronary Stent System BioFreedom™ Ultra
Morges 19 October 2020
Biosensors Announces Enrollment of First Patient in New Pivotal Drug Coated Balloon Trial
Morges 11 August 2020
Biosensors announces primary endpoint data release of the new US pivotal BioFreedom Trial – “LEADERS FREE II”
San Diego 22 September 2018
Biosensors International Announces Enrollment of First Patient in Pivotal Trial of New Coronary Microcatheter - "BIOMICS"
Morges 5th April 2022